Graeme’s amazing CAR T-cell therapy story – relapse to remission in 28 days
Just 28 days after Graeme Ardern had CAR T-cell therapy, he received the most amazing news - he’d had a complete metabolic response.
- Clinical trials
- Hodgkin lymphoma
Just 28 days after Graeme Ardern had CAR T-cell therapy, he received the most amazing news - he’d had a complete metabolic response.
When Julie Allen was diagnosed with lymphoma as a young professional mum, she thought she'd go straight back to work after treatment. But afterwards she literally felt “stripped bare”.
In this episode, Kate speaks with Ping, whose daughter Zoe was diagnosed with infant pre B-acute lymphoblastic leukaemia at just 5 weeks old. Zoe is now nearly 5 years old and is in remission and at school. Zoe's mother, Ping, shares what it was like to walk the blood cancer journey with a child so young, and how the family travelled around the world to save Zoe's life.
Michael Bowen was 33 years old and living in Sydney when one morning, as he was driving to work, he received a phone call that would stop his fast paced life in its tracks. Michael received a diagnosis of chronic myeloid leukaemia (CML). In this conversation, Michael talks about the bouts of depression he came up against and how he was able to overcome these hard times.
Megan Reid was about to begin her last two years of high school when she was diagnosed with a blood cancer.
For the third time, selinexor (Xpovio®) will be considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at its November 2022 meeting for the treatment of relapsed/refractory (R/R) myeloma.
During the 22 years Martin Boling has had myeloma, blood cancer of various types has affected four other members of his family too, not just him.
Meet the research team developing a myeloma treatment with maximum efficacy and minimal side effects
When Nikita was born with leukaemia in August 2019 his parents were told he probably wouldn’t survive; his chances being only 4%.
More than 80% of children newly diagnosed with acute lymphoblastic leukaemia (ALL) are successfully treated today – an achievement deemed by Dr Michael Osborn as “one of the true success stories of modern medicine”.